BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36754005)

  • 1. Nephrotoxin Exposure and Acute Kidney Injury in Adults.
    Griffin BR; Wendt L; Vaughan-Sarrazin M; Hounkponou H; Reisinger HS; Goldstein SL; Jalal D; Misurac J
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):163-172. PubMed ID: 36754005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
    Uber AM; Montez-Rath ME; Kwiatkowski DM; Krawczeski CD; Sutherland SM
    Pediatr Nephrol; 2018 Nov; 33(11):2193-2199. PubMed ID: 29987455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients.
    Benoit SW; Goldstein SL; Dahale DS; Haslam DB; Nelson A; Truono K; Davies SM
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1654-1658. PubMed ID: 31048085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
    Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
    J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
    [No Abstract]   [Full Text] [Related]  

  • 6. Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis.
    Su G; Xiao C; Cao Y; Gao P; Xie D; Cai Q; Nie S; Liu X; Lu F; Zhou Y; Hu Y; Li H; Yang Q; Wan Q; Liu B; Xu H; Li G; Weng J; Xu G; Chen C; Liu H; Shi Y; Zha Y; Kong Y; Tang Y; Shen J; Johnson DW; Xu X; Hou FF
    Int J Antimicrob Agents; 2023 Jan; 61(1):106691. PubMed ID: 36372344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury.
    Goldstein SL; Kirkendall E; Nguyen H; Schaffzin JK; Bucuvalas J; Bracke T; Seid M; Ashby M; Foertmeyer N; Brunner L; Lesko A; Barclay C; Lannon C; Muething S
    Pediatrics; 2013 Sep; 132(3):e756-67. PubMed ID: 23940245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
    Buckley MS; Komerdelj IA; D'Alessio PA; Rangan P; Agarwal SK; Tinta NC; Martinez BK; Ziadat DS; Yerondopoulos MJ; Kobic E; Kane-Gill SL
    J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
    Robertson AD; Li C; Hammond DA; Dickey TA
    Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
    Karino S; Kaye KS; Navalkele B; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Pogue JM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3743-50. PubMed ID: 27067325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
    Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
    J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
    Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
    Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
    Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
    Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
    Young J; Dahale D; Demmel K; O'Brien M; Geller J; Courter J; Haslam DB; Danziger-Isakov L; Goldstein SL
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28396. PubMed ID: 32495508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
    Blair K; Covington EW
    Ann Pharmacother; 2020 Nov; 54(11):1096-1101. PubMed ID: 32406243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.
    Blears EE; Morris J; Popp D; Lee JO; Norbury WB
    Surg Infect (Larchmt); 2022 Aug; 23(6):516-524. PubMed ID: 35736797
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
    Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
    Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit.
    Stoops C; Stone S; Evans E; Dill L; Henderson T; Griffin R; Goldstein SL; Coghill C; Askenazi DJ
    J Pediatr; 2019 Dec; 215():223-228.e6. PubMed ID: 31761141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
    Kiley PS; Pearston AP; Hodge LA; Kaplan MC; Baczek SM; Stanley JS; Wilson TJ; Soriano KM; Yao A; Shaeffer ZA; Talt IE; Cohen JA; Ingemi AI
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0004022. PubMed ID: 35867523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.